The Republican Party is at a critical crossroads, facing electoral hurdles in 2028 and potential losses in the House of ...
The biotech reported data from KOASTAL-1, the first of three phase 3 trials of navacaprant in major depressive disorder. Investigators randomized 383 people to receive the oral kappa opioid ...
On3 Sports estimates Quinn Ewers’ NIL valuation at $4.3 million. In his third year as the starting quarterback for the Texas Longhorns, Ewers, has etched his name among the program’s all-time greats.
HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”) today announced that the first patient has been dosed in the Phase III clinical trial of JR-142 (INN ...
--(BUSINESS WIRE)--Sarepta Therapeutics ... enrollment and dosing is complete in EMERGENE (Study SRP-9003-301), a Phase 3 clinical trial of SRP-9003 (bidridistrogene xeboparvovec).